Press release
Acute Respiratory Distress Syndrome (ARDS) Market 2024 : Market Size, Trends, Share Analysis To 2033
Acute Respiratory Distress Syndrome (ARDS) Market
The Business Research Company's Acute Respiratory Distress Syndrome (ARDS) Global Market Report 2024 identifies growing prevalence of pneumonia as the major driver for the Acute Respiratory Distress Syndrome (ARDS) market's growth in the forecast period. Pneumonia is an infection that affects one or both lungs, causing the lungs' air sacs, or alveoli, to fill up with fluid or pus. Pneumonia causes an inflammatory reaction in the lungs, increasing blood vessel permeability and fluid leakage into the alveoli.
The acute respiratory distress syndrome (ards) market size has grown rapidly in recent years. It will grow from $1.17 billion in 2024 to $1.29 billion in 2024 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to advancements in critical care medicine, aging population, pulmonary rehabilitation, multidisciplinary care teams.
The acute respiratory distress syndrome (ards) market size is expected to see rapid growth in the next few years. It will grow to $1.93 billion in 2028 at a compound annual growth rate (CAGR) of 10.7%.
Download Free Sample Of Acute Respiratory Distress Syndrome (ARDS) Market Report - https://www.thebusinessresearchcompany.com/sample_request?id=13005&type=smp
Major competitors in the Acute Respiratory Distress Syndrome (ARDS) market are Johnson & Johnson Services Inc., Novartis AG, GlaxoSmithKline PLC, Medtronic PLC, Boehringer Ingelheim International GmbH.
A key trend in the Acute Respiratory Distress Syndrome (ARDS) market includes major companies operating in the acute respiratory distress syndrome (ARDS). Aviptadil is a synthesized vasoactive intestinal peptide (VIP) that binds specifically to receptors on lung alveolar type II cells. For instance, in November 2022, Zuventus Healthcare Ltd., an India-based pharmaceutical manufacturing company, launched Aviptadil to treat acute respiratory distress syndrome. Aviptadil, a vasoactive intestinal peptide supplement, improves breathing and lowers mortality in ARDS patients. This is accomplished through Aviptadil's ability to protect and regenerate Type-2 Pneumocytes, restore Type-1 Pneumocytes, increase surfactant synthesis and suppress IL-6 (interleukin 6) and tumor necrosis factor (TNF)-alpha.
Read More On TheGlobal Acute Respiratory Distress Syndrome (ARDS) Market Report Here:
https://www.thebusinessresearchcompany.com/report/acute-respiratory-distress-syndrome-ards-global-market-report
The Acute Respiratory Distress Syndrome (ARDS) market is segmented -
• By Type: Diagnosis, Treatment
• By Cause: COVID-19 Disease 2019 (COVID-19), Sepsis, Inhalation Of Harmful Substances, Severe Pneumonia, Other Causes
• By Severity: Mild, Moderate, Severe
• By End User: Hospitals, Clinics, Ambulatory Service Centers, Other End Users
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Acute Respiratory Distress Syndrome (ARDS) market.
The Business Research Company's "Global Acute Respiratory Distress Syndrome (ARDS) Market Report 2024" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Acute Respiratory Distress Syndrome (ARDS) Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13005
The Table Of Content For The Acute Respiratory Distress Syndrome (ARDS) Market Include:
1. Executive Summary
2. Acute Respiratory Distress Syndrome (ARDS) Market Characteristics
3. Acute Respiratory Distress Syndrome (ARDS) Market Trends And Strategies
4. Acute Respiratory Distress Syndrome (ARDS) Market - Macro Economic Scenario
5. Global Acute Respiratory Distress Syndrome (ARDS) Market Size and Growth
…
32. Global Acute Respiratory Distress Syndrome (ARDS) Market Competitive Benchmarking
33. Global Acute Respiratory Distress Syndrome (ARDS) Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Acute Respiratory Distress Syndrome (ARDS) Market
35. Acute Respiratory Distress Syndrome (ARDS) Market Future Outlook and Potential Analysis
36. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn:https://in.linkedin.com/company/the-business-research-company
Twitter:https://twitter.com/tbrc_info
Facebook:https://www.facebook.com/TheBusinessResearchCompany
YouTube:https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog:https://blog.tbrc.info/
Healthcare Blog:https://healthcareresearchreports.com/
Global Market Model:https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases:https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultantsspecialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acute Respiratory Distress Syndrome (ARDS) Market 2024 : Market Size, Trends, Share Analysis To 2033 here
News-ID: 3327816 • Views: …
More Releases from The Business research company
Future of the Renal Denervation Devices Market: Strategic Analysis and Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Renal Denervation Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for renal denervation devices has witnessed a substantial expansion in recent times. The market, from being valued at $0.55 billion in 2024, is projected to escalate to $0.74 billion by 2025, exhibiting…
Emerging Trends to Drive Tuberculosis Diagnostics Market Growth at 7.7% CAGR Thr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Tuberculosis Diagnostics Market Size Growth Forecast: What to Expect by 2025?
Over the past few years, the tuberculosis diagnostics market has seen substantial growth. Projected growth suggests an increase from $2.21 billion in 2024 to $2.34 billion in 2025, at a compound annual growth rate (CAGR) of 5.9%. Factors…
Comprehensive Surgical Sealants And Adhesives Market Forecast 2025-2034: Growth …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Surgical Sealants And Adhesives Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the past few years, the market size of surgical sealants and adhesives has seen significant growth. The market, which currently stands at $2.75 billion in 2024, is expected to increase to $2.96…
Key Trends Influencing the Growth of the Preoperative Infection Prevention And W …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Preoperative Infection Prevention And Wound Cleansing Devices Market Through 2025?
In the past few years, there has been significant growth in the market size of preoperative infection prevention and wound cleaning devices. The market is projected to expand from $2.18 billion in…
More Releases for ARDS
Acute Respiratory Distress Syndrome (ARDS) Treatment Market Intelligence Size, S …
DataM Intelligence unveils its latest report on the "Acute Respiratory Distress Syndrome Treatment Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential…
Impact Of Increasing Pneumonia Prevalence On The Acute Respiratory Distress Synd …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Acute Respiratory Distress Syndrome (ARDS) Industry Market Size Be by 2025?
The market size for acute respiratory distress syndrome (ARDS) has experienced accelerated growth in the recent past. The market is expected to expand from $1.29 billion in 2024 to $1.42 billion in 2025, boasting a…
Acute Respiratory Distress Syndrome (ARDS) Market Size, Growth And Analysis Repo …
The Business Research Company recently released a comprehensive report on the Global Acute Respiratory Distress Syndrome (ARDS) Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, the opioids…
Acute Respiratory Distress Syndrome Market | ARDS Therapies, Clinical trials, AR …
As per DelveInsight, the Acute Respiratory Distress Syndrome Market is anticipated to grow immensely in the coming years owing to the launch of upcoming therapies and the increase in the incident population of ARDS in the 7MM.
DelveInsight's "Acute Respiratory Distress Syndrome Market Insights, Epidemiology, and Market Forecast 2034 [https://www.delveinsight.com/report-store/acute-respiratory-distress-syndrome-ards-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Acute Respiratory Distress Syndrome market…
U.S. Acute Respiratory Distress Syndrome (ARDS) Market Size, Share, Industry, Fo …
The U.S. Acute Respiratory Distress Syndrome (ARDS) Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global U.S. Acute Respiratory Distress Syndrome (ARDS) market. This report explores all the key factors affecting the…
Acute Respiratory Distress Syndrome (ARDS) Market Size to Reach USD 18,559.22 Mi …
Data Bridge Market Research completed a qualitative study titled "Acute Respiratory Distress Syndrome (ARDS) Market" with 100+ market data tables, pie charts, graphs, and figures spread across Pages and an easy-to-grasp full analysis. The most up-to-date technology was used in conjunction with expert industry knowledge and practical, effective, and innovative solutions to develop this Acute Respiratory Distress Syndrome (ARDS) report. Market penetration-increasing tactics such as new product releases, geographical expansion,…
